Personalized Medicine

CALM-QE is a project focused on addressing the challenges posed by Chronic Obstructive Pulmonary Disease (COPD) and bronchial asthma (BA), two prevalent non-communicable pulmonary diseases with significant socio-economic implications. These conditions are influenced by intricate interactions between genes and the environment, resulting in diverse phenotypes and endotypes that can overlap between COPD and BA.

The PM4Onco project aims to establish a long-term infrastructure for integrating and analyzing research and healthcare data, advancing the implementation of personalized cancer therapy in clinical practice. PM4Onco, which stands for “Personalized Medicine for Oncology,” refers to new therapies that specifically target cancer based on its individual characteristics.

Due to the increasing digitalisation in medicine, more and more data is becoming available. Yet, the challenge is to make the knowledge contained in this data available and usable at the point of care, especially, when making therapy decisions.